{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:34:32Z","timestamp":1761129272133},"reference-count":29,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2016]]},"DOI":"10.7883\/yoken.jjid.2014.501","type":"journal-article","created":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T18:05:12Z","timestamp":1436465112000},"page":"109-112","source":"Crossref","is-referenced-by-count":9,"title":["Risk Factors for Colistin-Associated Acute Kidney Injury: A Multicenter Study from Turkey"],"prefix":"10.7883","volume":"69","author":[{"given":"Serdar","family":"Gul","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Kirikkale University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferit","family":"Kuscu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Numune Educational and Research Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hande","family":"Aydemir","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Bulent Ecevit University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dogan Baris","family":"Ozturk","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Ulucanlar Eye Educational and Research Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozcan","family":"Deveci","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Dicle University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fazilet","family":"Duygu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Gaziosmanpasa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgul","family":"Kacmaz","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Kirikkale University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferda","family":"Yaman","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Reanimation, Kirikkale University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emel","family":"Aslan","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Dicle University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Peleg AY, Seifert H, Paterson DL. <i>Acinetobacter baumannii<\/i>: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21:538-82.","DOI":"10.1128\/CMR.00058-07"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lewis JR, Lewis SA. Colistin interactions with the mammalian urothelium. Am J Physiol Cell Physiol. 2004;286:C913-22.","DOI":"10.1152\/ajpcell.00437.2003"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Justo JA, Bosso JA. Adverse reactions associated with systemic polymyxin therapy. Pharmacotherapy. 2015;35:28-33.","DOI":"10.1002\/phar.1493"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Sorli L, Luque S, Grau S, et al. Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study. BMC Infect Dis. 2013;13:380.","DOI":"10.1186\/1471-2334-13-380"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yahav D, Farbman L, Leibovici L, et al. Colistin: new lessons on an old antibiotic. Clin Microbiol Infect. 2012;18:18-29.","DOI":"10.1111\/j.1469-0691.2011.03734.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Balkan II, Dogan M, Durdu B, et al. Colistin nephrotoxicity increases with age. Scand J Infect Dis. 2014;46:678-85.","DOI":"10.3109\/00365548.2014.926021"},{"key":"7","unstructured":"7. Lameire N. The definitions and staging systems of acute kidney injury and their limitations in practice. Arab J Nephrol Transplant. 2013;6:145-52."},{"key":"8","unstructured":"8. National Guideline Clearing House. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1-138."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Aydemir H, Akduman D, Piskin N, et al. Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant <i>Acinetobacter baumanni<\/i> ventilator-associated pneumonia. Epidemiol Infect. 2013;141:1214-22.","DOI":"10.1017\/S095026881200194X"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tuon FF, Rigatto MH, Lopes CK, et al. Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium. Int J Antimicrob Agents. 2014;43:349-52.","DOI":"10.1016\/j.ijantimicag.2013.12.002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zaidi ST, Al Omran S, Al Aithan AS, et al. Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria. J Clin Pharm Ther. 2014;39:272-6.","DOI":"10.1111\/jcpt.12138"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Horan TC, Andrus M, Dudeck MA. CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309-32.","DOI":"10.1016\/j.ajic.2008.03.002"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kwon JA, Lee JE, Huh W, et al. Predictors of acute kidney injury associated with intravenous colistin treatment. Int J Antimicrob Agents. 2010;35:473-7.","DOI":"10.1016\/j.ijantimicag.2009.12.002"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Doshi NM, Mount KL, Murphy CV. Nephrotoxicity associated with intravenous colistin in critically ill patients. Pharmacotherapy. 2011;31:1257-64.","DOI":"10.1592\/phco.31.12.1257"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Y&#x131;lmaz GR, Ba&#x15F;tu&#x11F; AT, But A, et al. Clinical and microbiological efficacy and toxicity of colistin in patients infected with multidrug-resistant gram-negative pathogens. J Infect Chemother. 2013;19:57-62.","DOI":"10.1007\/s10156-012-0451-2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Santamaria C, Mykietiuk A, Temporiti E, et al. Nephrotoxicity associated with the use of intravenous colistin. Scand J Infect D&#304;s. 2009;41:767-9.","DOI":"10.1080\/00365540903147001"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Pogue JM, Lee J, Marchaim D, et al. Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system. Clin Infect Dis. 2011;53:879-84.","DOI":"10.1093\/cid\/cir611"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. DeRyke CA, Crawford AJ, Uddin N, et al. Colistin dosing and nephrotoxicity in a large community teaching hospital. Antimicrob Agents Chemother. 2010;54:4503-5.","DOI":"10.1128\/AAC.01707-09"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Falagas ME, Fragoulis KN, Kasiakou SK, et al. Nephrotoxicity of intravenous colistin: a prospective evaluation. Int J Antimicrob Agents. 2005;26:504-7.","DOI":"10.1016\/j.ijantimicag.2005.09.004"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Falagas ME, Kasiakou SK, Kofteridis DP, et al. Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria. Eur J Clin Microbiol Infect Dis. 2006;25:596-9.","DOI":"10.1007\/s10096-006-0191-2"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Falagas ME, Rizos M, Bliziotis IA, et al. Toxicity after prolonged (more than four weeks) adminstration of intravenous colistin. BMC Infect Dis. 2005;5:1.","DOI":"10.1186\/1471-2334-5-1"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kift EV, Maartens G, Bamford C. Systematic review of the evidence for rational dosing of colistin. S Afr Med J. 2014;104:183-6.","DOI":"10.7196\/samj.7011"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Garonzik SM, Li J, Thamlikitkul V, et al. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother. 2011;55:3284-94.","DOI":"10.1128\/AAC.01733-10"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kim J, Lee KH, Yoo S, et al. Clinical characteristics and risk factors of colistin-induced nephrotoxicity. Int J Antimicrob Agents. 2009;34:434-8.","DOI":"10.1016\/j.ijantimicag.2009.06.028"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Rattanaumpawan P, Ungprasert P, Thamlikitkul V. Risk factors for colistin-associated nephrotoxicity. J Infect. 2011;62:187-90.","DOI":"10.1016\/j.jinf.2010.11.013"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Turkoglu M, Dizbay M, Ciftci A, et al. Colistin therapy in critically ill patients with chronic renal failure and its effect on development of renal dysfunction. Int J Antimicrob Agents. 2012;39:142-5.","DOI":"10.1016\/j.ijantimicag.2011.10.006"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Wu X, Zhang W, Ren H, et al. Diuretics associated acute kidney injury: clinical and pathological analysis. Ren Fail. 2014;36:1051-5.","DOI":"10.3109\/0886022X.2014.917560"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Alassar A, Roy D, Abdulkareem N, et al. Acute kidney injury after transcatheter aortic valve implantation: incidence, risk factors, and prognostic effects. Innovations (Phila). 2012;7:389-93.","DOI":"10.1177\/155698451200700603"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Ulucay C, Eren Z, Kaspar EC, et al. Risk factors for acute kidney injury after hip fracture surgery in the elderly individuals. Geriatr Orthop Surg Rehabil. 2012;3:150-6.","DOI":"10.1177\/2151458512473827"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/69\/2\/69_JJID.2014.501\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T23:46:01Z","timestamp":1566949561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/69\/2\/69_JJID.2014.501\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2014.501","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}